Model
Edge
Arca Biopharma Inc.
ABIO
Filing type
8-K
Filing date
Apr 29, 2026
Updated
Apr 30, 2026 ยท 3:30 PM
Copy reference
Filing
8-K
Financial Results, Other Events
Exhibits
EX-1.1
UNDERWRITING AGREEMENT BY AND AMONG ORUKA THERAPEUTICS, INC. AND LEERINK PARTNERS LLC, TD SECURITIES (USA) LLC, GOLDMAN SACHS & CO. LLC, STIFEL, NICOLAUS & COMPANY
EX-5.1
OPINION OF DAVIS POLK & WARDWELL LLP
EX-99.1
Financial Results, Other Events
GRAPHIC
Graphic